STERIS plc

STE Healthcare Medical Devices

STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025.

Revenue
+8.79%
EPS
+12.8%
Free cash flow
+43.6%
Total debt
−0.21%

Quarter to September 2026, against a year earlier

253.19 0.93 −0.37%
Market cap
$24.8B
P/E
30.0×
Fwd P/E
25.1×
Dividend yield
1.02%
F-score
9/9
Altman Z
5.10
Beneish M
−2.68
Dividend safety
86/100

STERIS plc (STE) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, STERIS plc (STE) trades at a EV/Sales of 4.2×. Over the past ten years it has ranged from 2.2× (August 2015) to 7.2× (December 2021); the current reading is higher than 43% of that period. That is above the Medical Devices industry median of 2.7× and above the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2026 3.9× (11.87%)
FY2025 4.4× (8.22%)
FY2024 4.8× (0.08%)
FY2023 4.8× (22.39%)
FY2022 6.2× 9.53%
FY2021 5.7× 35.61%
FY2020 4.2× (0.57%)
FY2019 4.2× 24.87%
FY2018 3.4× 23.79%
FY2017 2.7× (3.64%)

Quarterly newest first

Period EV/Sales Change
Sep 2026 3.5× (2.83%)
Jun 2026 3.6× (6.95%)
Mar 2026 3.9× (14.00%)
Dec 2025 4.5× (0.49%)
43 more quarters

Against its own ten years

Low 2.2× High 7.2×
Ten-year median 4.4×
Current reading's percentile 38

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on STE